
    
      A two arm study (1 Active, 1 Active control) to compare the incidence, progression and
      severity of chronic renal allograft failure in at-risk patients who are converted from
      cyclosporine-based to tacrolimus-based immunosuppression to patients who remain on
      cyclosporine-based therapy
    
  